Imprese · 23/04/20011 min di lettura
Studies of Adverse Effects of Marketed Drugs; Availability of Grants (Cooperative Agreements); Request for Applications; Correction
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of April 4, 2001 (66 FR 17907). The document announced the anticipated availability of funds for cooperative agreements to study adverse affects of drugs marketed in the United States and its territories. The document was published with some inadvertent errors. This document corrects those errors.